The treatment of ventricular arrhythmias: evaluation of standard therapy and recent advances.
D000137:Acid-Base Imbalance / Q000628:therapy; D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use; D000889:Anti-Arrhythmia Agents / Q000145:classification / Q000627:therapeutic use; D001145:Arrhythmias, Cardiac / Q000139:chemically induced / Q000188:drug therapy / Q000628:therapy*; D001950:Bretylium Tosylate / Q000627:therapeutic use; D003325:Coronary Care Units; D003645:Death, Sudden; D004071:Digitalis Glycosides / Q000009:adverse effects; D004206:Disopyramide / Q000627:therapeutic use; D004491:Edrophonium / Q000627:therapeutic use; D004554:Electric Countershock; D006352:Heart Ventricles; D006801:Humans; D009204:Myocardial Revascularization; D010138:Pacemaker, Artificial
D000319:Adrenergic beta-Antagonists; D000889:Anti-Arrhythmia Agents; D004071:Digitalis Glycosides; D004491:Edrophonium; D001950:Bretylium Tosylate; D004206:Disopyramide